Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension - Wikidata - awgldk - TriplyDB

Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension

Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension

http://www.wikidata.org/entity/Q33987980

about

Genetics of resistant hypertension: a novel pharmacogenomics phenotype Resistant Hypertension and Renal Nerve Denervation Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.Lifestyle modification for resistant hypertension: The TRIUMPH randomized clinical trial PTPRD gene associated with blood pressure response to atenolol and resistant hypertension Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study Cardiovascular and renal complications in patients with resistant hypertension.Recent advances in the management of resistant hypertension Quality of Life in Treatment-Resistant Hypertension.Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled?Resistant Hypertension: Mechanisms and Treatment.Recognition and Management of Resistant Hypertension.Resistant Hypertension: An Incurable Disease or Just a Challenge For Our Medical Skill?Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women's Heart Disease.Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.Health-related quality of life in persons with apparent treatment-resistant hypertension on at least four antihypertensives.Increased afterload following myocardial infarction promotes conduction-dependent arrhythmias that are unmasked by hypokalemia.Reducing women's cardiovascular disease risk profile.Clinical characteristics, target organ damage and associate risk factors of resistant hypertension determined by ambulatory blood pressure monitoring in patients aged ≥ 80 years.Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.Refractory versus resistant hypertension: Novel distinctive phenotypes.[Therapy-resistant hypertension].Resistant Hypertension and Susceptible Outcomes: Exploring the Benefits of Aggressive Blood Pressure Control.

P2860

Q26851506-D062BC46-1836-4324-B553-DD57201584A9 Q28079842-D020999F-E6EB-48C9-828C-5EEEBE97CBD4 Q33658284-BF549186-DEC5-4F79-84D1-3B095CDD9108 Q35115111-A1E1A2DE-FFCD-4E5E-81A0-F00022555BBC Q36016796-146487A7-58F5-4734-BBD2-2FD031A8766D Q36258974-7B5C562C-D7FB-419B-AFBC-6D41130A40F6 Q36677516-4B8B7FF4-05D8-4DDE-BFDC-4F9B6B6FFEDC Q36792041-9EEA692B-B675-4442-8459-7F99F01EB8D1 Q37648463-51D22E16-6CB8-4065-A58F-521DACD3E6E7 Q38235630-3E739BF8-FDDA-4282-8F20-89147BD86D16 Q38364197-4F2140E3-A29E-4140-A3DC-B72EA2364577 Q38538689-0BFA990D-B8B6-4A32-B3C9-46C66D8A2D6B Q38569663-96F91028-CFE9-4685-BC6F-6037C1ECF28A Q38734859-61D8DB87-12C4-42CA-BA9C-8099A76E68D5 Q38789707-C2516F81-BF31-4D3E-84D1-61651058CE6E Q38836425-0B761B9D-990C-4F2B-BD35-C94525E44A54 Q39736861-E45A710A-2BDE-4AC1-9EBC-62AA59CB011D Q40052463-D220FE6F-784F-44C6-84EF-AEE64C37E69D Q40826247-DABC4FC7-4DF3-4FC3-9BF3-6A58AFD24E8E Q41296175-2AE09248-B247-48E8-BC39-A247B9DCCA35 Q41648227-9893ECB8-209B-4188-B547-971AFE3C726A Q42209115-07A061BB-5601-478E-A3D2-F707960316C6 Q42373752-AFAFE53E-3697-48BD-9F7F-B1F9E48507C1 Q42376948-1A607801-67DF-4923-86DB-0626D455A818 Q53632077-D8A67F6B-12E8-4FDA-9D14-C36160A4A980 Q53814916-BBD48E23-C3AD-4D48-B707-687938C45C27

P2860

Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension

http://www.wikidata.org/entity/Q33987980

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Predictors and outcomes of res ...... rtery disease and hypertension

@ast

Predictors and outcomes of res ...... rtery disease and hypertension

@en

type

label

Predictors and outcomes of res ...... rtery disease and hypertension

@ast

Predictors and outcomes of res ...... rtery disease and hypertension

@en

prefLabel

Predictors and outcomes of res ...... rtery disease and hypertension

@ast

Predictors and outcomes of res ...... rtery disease and hypertension

@en

P1433

Q33987980-72C60EF1-364C-465F-A9BA-FE1B97BF10C3

P1476

Q33987980-1D9E0E16-085D-41EE-A3D3-1E05172D4D8E

P2093

Q33987980-00E08C2F-E559-45D3-89A6-53277B601808

Q33987980-2202B223-8D3B-41C7-B6D9-E9A1746E596C

Q33987980-3F3130BB-B624-43B6-BE92-8A6D01EC99F3

Q33987980-53CAFC09-BB65-4357-82BD-A88E6C6F1EED

Q33987980-A0D51516-2509-4B53-9B2B-CAEA27E2B7ED

Q33987980-A1036BAA-4558-4252-8518-DB6AF235C42B

Q33987980-FB5F35CC-1450-4B30-A594-91B2738F0C29

P2860

Q33987980-04C63BC5-A7F7-438F-91D2-E7B5CAD50036

Q33987980-0AEF2273-03FB-4E8E-98CE-64747A0B7F96

Q33987980-137D3056-FA09-42F5-9D09-CCBD194C6456

Q33987980-2326489D-1C8E-4284-AEF9-18C2502B6957

Q33987980-408F2CEC-A83D-4603-9C72-D378A6CD0453

Q33987980-5111C9E4-6333-4354-89C6-30799590566D

Q33987980-56688FFA-F9D5-4A88-8391-5C498EF1AE06

Q33987980-567685F5-192A-4F50-9D23-59E070FA11BC

Q33987980-567B7ECE-47B5-4AF2-B96C-714EB478E3C3

Q33987980-5A4AC930-2B07-493B-A9DA-D4F4DECEAF5B

P304

Q33987980-DDCA8CD8-FC16-49AB-B401-8ACA7B405602

P31

Q33987980-EB9930C1-C5CF-43C5-A1E5-46E589B66205

P356

Q33987980-97B14158-7329-4151-AE39-896D047CD911

P433

Q33987980-E3BCFB08-FA91-40D9-8186-F27EED0F3B21

P478

Q33987980-26C91C50-FA5E-4B66-8BBC-C68DA2B18192

P50

Q33987980-473FA4A9-F8CD-45B7-BF8F-EA05B8B45B6B

Q33987980-47D21D13-4915-4F8D-8860-C2417B49E9A5

P577

Q33987980-9194E4DF-C047-4E10-90B4-6A0327946F09

P698

Q33987980-7D9DEC16-C4AE-4F85-A216-28B467CEBE61

P921

Q33987980-8862E504-7793-4133-8CEC-EA5104079D27

P932

Q33987980-333918FF-FCF2-4C7D-992E-CBD67E3A4BB9

P356

HJH.0000000000000051

P1433

Journal of Hypertension

P1476

Predictors and outcomes of res ...... rtery disease and hypertension

@en

P2093

Ali Ahmed

http://www.w3.org/2001/XMLSchema#string

Anthony A Bavry

http://www.w3.org/2001/XMLSchema#string

Franz H Messerli

http://www.w3.org/2001/XMLSchema#string

George L Bakris

http://www.w3.org/2001/XMLSchema#string

Rhonda M Cooper-Dehoff

http://www.w3.org/2001/XMLSchema#string

Steven M Smith

http://www.w3.org/2001/XMLSchema#string

Yan Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008

Incidence and prognosis of resistant hypertension in hypertensive patients.

Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind.

Effects of antihypertensive drugs on arterial stiffness

P304

635-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/HJH.0000000000000051

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Eileen M Handberg

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24299915

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

4118668

http://www.w3.org/2001/XMLSchema#string